Coalesenz Inc.

Coalesenz Inc. is tackling a critical healthcare need with its innovative approach to coagulation management. The company's smart sensor offers a timely solution for measuring a patient’s blood coagulation status using a small blood sample, addressing the unmet need to identify and manage patients at risk of life-threatening bleeding or thrombosis. This advancement holds the potential to significantly impact the prevention of in-hospital preventable deaths, attributed to these conditions. Moreover, the device complements traditional medical care by enabling coagulation testing at home, catering to the 15M patients worldwide receiving oral anticoagulants, thus contributing to the prevention of venous or arterial thrombosis, a leading cause of global mortality. With its focus on Biotechnology, Health Care, Life Sciences, and Medical Devices, Coalesenz Inc. is positioning itself at the forefront of medical technology. Founded in 2020 and headquartered in the United States, the company's commitment to addressing critical healthcare challenges makes it a compelling opportunity for potential investors in the healthcare and biotechnology sectors.